Fred Tanada is a Senior Advisor and veteran operator specializing in scaling high-growth technology companies within complex, highly regulated industries. As a former founder and executive, Fred is best known for his instrumental role in building Curative from its early stages into a healthcare unicorn. Under his leadership, the organization scaled to serve over 36 million patients, managed a workforce of 10,000+ employees, and successfully navigated a high-stakes pivot from diagnostics into the insurance market.

A Y Combinator alumnus with deep roots in Silicon Valley, Fred has a proven track record of securing capital from the world’s most prestigious venture firms, including Andreessen Horowitz (a16z). His expertise lies at the intersection of technological innovation and regulatory strategy, helping startups transform disruptive ideas into institutional-scale platforms.

Beyond his operational work, Fred leverages an elite global network to support the next generation of innovators. He is a Forbes 30 Under 30 honoree and maintains deep connectivity with the Thiel Foundation, the Y Combinator partner network, and Tier-1 VCs. Within the healthcare sector, he serves as a strategic bridge to US government bodies and major insurance carriers, providing founders with the regulatory "moat" and payer relationships necessary to dominate the market.